ORPHAN SYNERGY EUROPE-PHARMA (EPA:OSE) | WebDisclosure

Basculer en Français

9821	Companies
197095	Keywords
128171	Articles
104822	Press releases

Headlines Articles Press releases ORPHAN SYNERGY EUROPE-PHARMA

Home
Companies
ORPHAN SYNERGY EUROPE-PHARMA

PRESS RELEASE

published on 09/30/2025 at 19:30, 4 months 7 days ago

Renouvellement complet du Conseil d'administration Élection du Dr Markus Cappel en tant que Président du Conseil d'administration
Renouvellement complet du Conseil d'administration d'OSE Immunotherapeutics avec l'élection du Dr Markus Cappel comme Président. Assemblée Générale tenue à Paris. Nouveau Président se félicite de l'avenir prometteur de la Société

Assemblée Générale Conseil D'administration Renouvellement OSE Immunotherapeutics Dr Markus Cappel
BRIEF

published on 09/26/2025 at 07:05, 4 months 12 days ago

Partenariat stratégique pour l'innovation en immunothérapie

Partenariat Stratégique Oncologie Soutien Industriel Innovation Immunothérapie Recherche Collaborative
BRIEF

published on 09/26/2025 at 07:05, 4 months 12 days ago

Strategic Partnership for Innovation in Immunotherapy

Strategic Partnership Oncology Industrial Support Immunotherapy Innovation Collaborative Research
PRESS RELEASE

published on 09/26/2025 at 07:00, 4 months 12 days ago

OSE Immunotherapeutics, Inserm Transfert et Nantes Université annoncent un partenariat stratégique pour accélérer l’innovation en immunothérapie
Partenariat stratégique entre OSE Immunotherapeutics, Inserm Transfert et Nantes Université pour accélérer l'innovation en immunothérapie. Objectif : transformer découvertes académiques en thérapies de rupture

Partenariat Immunothérapie OSE Immunotherapeutics Inserm Transfert Nantes Université
PRESS RELEASE

published on 09/26/2025 at 07:00, 4 months 12 days ago

OSE Immunotherapeutics, Inserm Transfert and Nantes University Announce Strategic Partnership to Accelerate Innovation in Immunotherapy
OSE Immunotherapeutics, Inserm Transfert, and Nantes University form a strategic partnership to advance immunotherapy for oncology, inflammation, and autoimmunity. The collaboration combines academic research and industrial expertise

Innovation Partnership Oncology Collaboration Immunotherapy
BRIEF

published on 09/24/2025 at 08:05, 4 months 14 days ago

OSE Immunotherapeutics corrige une erreur de droit de vote avant l'assemblée générale

Droit De Vote Assemblée Des Actionnaires Erreur Matérielle Accusations Sociétés De Procuration
BRIEF

published on 09/24/2025 at 08:05, 4 months 14 days ago

OSE Immunotherapeutics Corrects Voting Rights Error Before General Meeting

Voting Rights Shareholder Meeting Accusations Material Error Proxy Firms
PRESS RELEASE

published on 09/24/2025 at 08:00, 4 months 14 days ago

Correction of a Material Error Relating to the Total Number of Voting Rights and Shares Comprising the Share Capital
OSE Immunotherapeutics corrects material error in total number of shares and voting rights, refutes accusations, and provides clarity on shareholder agreements and proxy advisory recommendations

Correction Proxy Advisory Shareholder Agreements OSE Immunotherapeutics Material Error
BRIEF

published on 09/23/2025 at 22:35, 4 months 14 days ago

OSE Immunotherapeutics répond à la décision du tribunal

Assemblée Générale Droits Des Actionnaires OSE Immunotherapeutics Tribunal De Commerce De Nantes Erreur Relative Aux Droits De Vote
BRIEF

published on 09/23/2025 at 22:35, 4 months 14 days ago

OSE Immunotherapeutics Responds to Court Decision

General Meeting Shareholder Rights OSE Immunotherapeutics Nantes Commercial Court Voting Rights Error

Accesswire

Published on 02/07/2026 at 01:00, 1 day 8 hours ago

Green Bridge Metals Can Help Secure U.S. Production of Critical Mineral Titanium
Published on 02/06/2026 at 23:10, 1 day 10 hours ago

Topline Capital Management, LLC Announces Disposition of Shares of NamSys Inc.
Published on 02/06/2026 at 22:01, 1 day 11 hours ago

Totec Resources Announces Listing of Shares on the Frankfurt Stock Exchange and Adoption of Omnibus Incentive Plan
Published on 02/06/2026 at 15:30, 1 day 18 hours ago

Vulcan Minerals Inc. - Drilling Program Update for the Carbonear Zinc-Lead SEDEX project in Newfoundland
Published on 02/06/2026 at 13:30, 1 day 20 hours ago

Redwood AI Corp. (formerly Marshall Technologies Corp.) Announces Closing of IPO and Listing of Shares on the Canadian Securities Exchange

View all ACCESSWIRE

EQS Group

Published on 02/07/2026 at 21:00, 12 hours 37 minutes ago

Alibaba Group Debuts 'Wonder on Ice,' an Immersive AI Experience at Milan’s Sforza Castle for Milano Cortina 2026
Published on 02/07/2026 at 16:35, 17 hours 2 minutes ago

The Ministry of Finance and the International Monetary Fund to launch tomorrow the second edition of the AlUla Conference for Emerging Market Economies
Published on 02/07/2026 at 16:20, 17 hours 17 minutes ago

NOTICE OF SETTLEMENT APPROVAL HEARING - SHORT FORM - WAYLAND GROUP CORP., SCOTT LANGILLE, GERHARD MÜLLER, PAUL PATHAK, ERIC SILVER, MICHAEL STEIN, JOHN DOES 1-3, CANACCORD GENUITY CORP., AND RF SECURITIES CLEARING LP (FORMERLY KNOWN AS GMP SECU
Published on 02/06/2026 at 19:25, 1 day 14 hours ago

Funding Circle Holdings plc: POS-Transaction in Own Shares
Published on 02/06/2026 at 17:52, 1 day 15 hours ago

EQS-Adhoc: Avemio AG: Preparation of the filing for insolvency proceedings by Teltec AG, a subsidiary of Avemio AG, and potential effects on the going-concern assessment of Avemio AG

Les Echos

Published on 02/06/2026 at 18:22, 1 day 15 hours ago

Déclaration du nombre d’actions et droits de vote au 31 janvier 2026
Published on 02/06/2026 at 18:22, 1 day 15 hours ago

Disclosure of Share Capital and Voting Rights as of January 31, 2026
Published on 02/06/2026 at 16:01, 1 day 17 hours ago

Notice of exercise of early redemption option of the subordinated note ISIN : FR0010093328
Published on 02/06/2026 at 16:01, 1 day 17 hours ago

Exercice de l’option de remboursement de l'instrument subordonné FR0010093328
Published on 02/06/2026 at 07:54, 2 days 1 hour ago

ENGIE - Déclaration du nombre total d'actions et de droits de vote au 31 janvier 2026

View all LES ECHOS COMFI WIRE